File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Advances in the clinical management of nasopharyngeal cancer
Title | Advances in the clinical management of nasopharyngeal cancer |
---|---|
Authors | |
Issue Date | 2014 |
Citation | The 16th Biennial Symposium of the International Association for Research on Epstein-Barr Virus and Associated Diseases (EBV 2014), Brisbane, Australia, 16-19 July 2014. How to Cite? |
Abstract | Nasopharyngeal carcinoma (NPC) is one of the most peculiar cancers with a distinctly skewed geographic and ethnic distribution. Epidemiological studies have unveiled its multifactorial etiology with a dynamic interplay of genetic predisposition, Epstein–Barr virus (EBV) infection and environmental carcinogens. Radiotherapy has been the mainstay of curative treatment. The use of highly precise intensity-modulation radiotherapy technique has achieved excellent locoregional control and reduced treatment toxicities. Combination chemotherapy with cisplatin-based regimen further improves treatment outcome. The refinement of radiotherapy technique, search for more potent systemic agents, contemporary treatment strategies for recurrent or metastatic diseases, biomarkers for prognostification and prediction of treatment response are currently under intense study. |
Description | Celebrating 50 years of Epstein-Barr virus discovery (1964-2014) Session 11: Clinical Aspects of EBV-associated malignancies |
Persistent Identifier | http://hdl.handle.net/10722/206038 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sze, CKH | en_US |
dc.contributor.author | Lee, AWM | en_US |
dc.date.accessioned | 2014-10-20T11:44:40Z | - |
dc.date.available | 2014-10-20T11:44:40Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | The 16th Biennial Symposium of the International Association for Research on Epstein-Barr Virus and Associated Diseases (EBV 2014), Brisbane, Australia, 16-19 July 2014. | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/206038 | - |
dc.description | Celebrating 50 years of Epstein-Barr virus discovery (1964-2014) | - |
dc.description | Session 11: Clinical Aspects of EBV-associated malignancies | - |
dc.description.abstract | Nasopharyngeal carcinoma (NPC) is one of the most peculiar cancers with a distinctly skewed geographic and ethnic distribution. Epidemiological studies have unveiled its multifactorial etiology with a dynamic interplay of genetic predisposition, Epstein–Barr virus (EBV) infection and environmental carcinogens. Radiotherapy has been the mainstay of curative treatment. The use of highly precise intensity-modulation radiotherapy technique has achieved excellent locoregional control and reduced treatment toxicities. Combination chemotherapy with cisplatin-based regimen further improves treatment outcome. The refinement of radiotherapy technique, search for more potent systemic agents, contemporary treatment strategies for recurrent or metastatic diseases, biomarkers for prognostification and prediction of treatment response are currently under intense study. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Biennial Symposium of the International Association for Research on Epstein-Barr Virus & Associated Diseases, EBV 2014 | en_US |
dc.title | Advances in the clinical management of nasopharyngeal cancer | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Sze, CKH: henrysze@graduate.hku.hk | en_US |
dc.identifier.email | Lee, AWM: awmlee@hkucc.hku.hk | en_US |
dc.identifier.authority | Sze, CKH=rp01697 | en_US |
dc.identifier.hkuros | 241239 | en_US |